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Abstract
Background: The aim of the study was to explore the acceptability and uptake of on-campus screening using a
youth friendly approach in two Third Level higher education institutions (HEIs). This study is part of wider research
exploring the optimal setting for chlamydia screening in Ireland.
Methods: Male and female students were given the opportunity to take a free anonymous test for chlamydia
during a one week programme of “pee-in-a-pot” days at two HEI campuses in the West of Ireland. The study was
set up after extensive consultation with the two HEIs and advertised on the two campuses using a variety of
media in the two weeks preceding the screening days. Screening involved the provision and distribution of testing
packs at communal areas and in toilet facilities. In Ireland, chlamydia notifications are highest amongst 20-29 year
olds and hence the screening criterion was aimed at 18-29 year olds. Urine samples were tested using a nucleic
acid amplification test (NAAT). Following the screening days, qualitative in-depth interviews were conducted with
participants about their experiences of the event.
Results: Out of 1,249 test kits distributed in two HEIs, 592 specimens were collected giving a return rate of 47.5%.
Tests excluded (54) were due to labelling errors or ineligibility of participants’ age. Two thirds of those tested were
females and the mean age was 21 years. Overall,3.9% (21/538) of participants tested positive, 5% (17/336) among
females and 2% (4/191) among males. Participant interviews identified factors which enhanced student
participation such as anonymity, convenience, accessibility of testing, and the informal and non-medical approach
to testing.
Conclusions: Screening for chlamydia using on-campus “pee-in-a-pot” days is an acceptable strategy in this
population. This model can detect and treat asymptomatic cases of chlamydia and avoid many of the barriers
associated with testing for sexually transmitted infections (STIs) in clinical settings.
Background
Chlamydia is the most prevalent bacterial sexually trans-
mitted infection (STI) in the western world [1]. In Ire-
land, the number of chlamydia notifications increased
from 245 in 1995 to 6290 in 2008 [2]. While this may
reflect a real rise in the burden of chlamydia infection,
it also reflects an increase in provider awareness in chla-
mydia testing, test performance [3] and the introduction
of laboratory notifications in Ireland in 2004. The real
burden (numbers of infection) is likely to be higher than
reported as chlamydia is asymptomatic in approximately
70% of women and 50% of men and thus may remain
undiagnosed [4]. Prevalence studies [5,6] in young Irish
people (including students) have shown similar rates of
infection to the UK and else where in Europe [7-9].
In view of the asymptomatic nature of chlamydia, espe-
cially in women, there is recognition [10-15] that it is
important to screen sexually active women aged less than
25 years [16]. Two approaches are proposed: (a) systema-
tic, where all eligible young persons are systematically
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unique identifier for each individual to ensure all eligible
persons are invited and not invited again except where
indicated; and (b) opportunistic, where eligible young
persons that are visiting/utilising clinical and non-clinical
settings are invited to take a test.
Opportunistic screening in clinical settings has limita-
tions [17] principally that it only reaches young people
who are already attending health care settings [18]. In
particular, men’s underutilisation of primary care ser-
vices means they may have few encounters with health
care professionals for screening offers [19-21]. This is
problematic as young adults are the highest risk group
for acquiring chlamydia infection [22,23]. Balfe et al.
reported that while young people expressed willingness
to take up offers of opportunistic screening, they had
major reservations about being offered screening by the
family doctor and practice staff (’familiar strangers’)
because of concerns about anonymity [24]. Other recog-
nised barriers for young people accessing sexual health
services for testing include cost and inconvenience, and
the fear and stigma commonly attached to STI testing
[25]. Opportunistic screening also relies on heath care
providers remembering to offer the test [26].
These issues highlight the need for additional strate-
gies for screening that are free at the point of testing,
easy to access, private and available in a variety of set-
tings [27-29]. Screening strategies need to be ‘youth
friendly’ and available outside of traditional medical
facilities. Previous innovative approaches have ranged
from screening in mobile vans to home testing, collect-
ing samples in parks and in schools, screening on
admission to residential settings such as detention facil-
ities, job training programmes and the military [30-33].
Screening locations, which have a ‘captive population’ -
schools, universities and correctional facilities, have
been used especially to reachm e n[ 3 4 , 3 5 ] .W h i l eL o r i -
mor et al. found young people especially men are willing
to participate in non-clinical screening [36]. Balfe et al.
found that screening needs to offer privacy from ‘ap u b -
lic audience’ with confidential testing [37].
The purpose of this study was to test the acceptability
and uptake of on-campus chlamydia screening in two
Irish HEI settings using a youth-friendly approach.
Young people in HEIs are a group of sexually active per-
sons who are at high risk of contracting STIs [38]. HEIs
are potentially important settings for STI screening in
most countries as they provide access to a large popula-
tion of young people. In Ireland the HEI student popu-
lation represents over 10% of the total population [39].
This study was part of wider research exploring the
optimal setting for chlamydia screening in Ireland which
also included a national pilot study. Ethical approval for
this study was granted by the Irish College of General
Practitioners and the Research Ethics Committee of the
National University of Ireland Galway, Ireland.
Methods
A sequential explanatory mixed method study design
that combines both quantitative and qualitative research
methods was used [40]. In mixed methods research
designs, researchers use both quantitative and qualitative
methods and data in the same study or series of studies;
in the sequential explanatory approach, qualitative find-
ings are used to explain and understand quantitative
findings [41]. Using both qualitative and quantitative
data in a study can produce more complete knowledge
needed to inform clinical practice [41]. The quantitative
data comprised of screening data results and qualitative
findings were from semi-structured interviews con-
ducted with students who took part in the event.
On-site screening
Study population
The study population was male and female students
attending two HEIs, a university and an institute of
technology, (student populations of 16,470 and 4,973) in
the West of Ireland. Irish HEIs include universities, col-
leges and institutes of technology. (Higher education is
the education level following the completion of a school
providing a secondary education such as high school or
a secondary school).
The total student population (full time and part time)
in the university consisted of 5,213 males and 7,336
females with 2,794 males and 2,026 females in the insti-
tute of technology. The highest attendants in both set-
tings were between the ages of 19-21 years [42].
Students from non-manual, skilled-manual, semi-skilled
and unskilled backgrounds are better represented in the
institute of technology with 32.4% compared to 26.3% in
the university sector [42].
Internationally, the highest rates of chlamydia are
documented as occurring in young people aged less
than 25 years [43]. In Ireland, the highest rates of noti-
fied cases are among those aged 20-29 years [44]. For
the purpose of the study, screening was aimed at men
and women aged 18-29 years.
Planning of screening programme
Several planning meetings were held with staff from the
student health units and student unions to plan logistics
and screening protocols (including treatment and fol-
low-up) for a publicised mass screening programme, to
be implemented during a one week ‘sexual health aware-
ness and guidance’ (SHAG) week, which is an annual
student event designed to promote positive sexual
health. Colourful posters and information leaflets
attracted attention to the program and were distributed
around campuses. Media releases, radio broadcasts,
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cise the event.
Testing packs
Testing packs (small specimen bags containing a 25 ml
urine container, a pen and an information card) were
designed for the study. Testing was anonymous and
each pack was identified through a unique code. Partici-
pants who chose to take a test were instructed to read
the information card, write their mobile number and
date of birth on the urine container, urinate in this con-
tainer and place it in the specimen bag. Information
leaflets on chlamydia testing were readily available and
distributed to participants which covered the following:
information on the research project including age criter-
ion, what is chlamydia and how it is transmitted and
diagnosed, what happens if the test is positive and infor-
mation on telling your previous/current partners. Addi-
tional information on local and national sexual health
services was also supplied. Consent for testing was
implied through the participation and provision of per-
sonal identifying details on the sample container. Speci-
men collection boxes were located inside toilet areas
where participants were instructed to drop their speci-
men bag. Testing packs were made available for three to
four hours each day during the one week screening
programme.
Project researchers collected the specimen bags and
transported them to the laboratory services each day
where the urine specimens were frozen and batch tested
with Polymerase Chain Reaction (PCR) testing technol-
o g y .T h et e s tu s e dw a st h eCOBAS® TaqMan® CT Test
v2.0 manufactured by Roche Diagnostics, Switzerland.
The sensitivity and specificity of this test (as per the
Roche Cobas Taqman CT test, v2.0 Preparation kit) is
reported as 95.7% and 99.8%. With a prevalence rate of
3.9%, the positive predictive value of this test in our
study population is 95.1%.
Peer volunteers
Student (peer) volunteers were recruited to distribute
testing packs and information leaflets to potential parti-
cipants and around the student campuses. The 35
volunteers were given an educational session on chlamy-
dia and the background to the research project. Volun-
teers were given incentives (€25 voucher) for their
participation (approximately four hours each). Volun-
teers were dressed informally and were easily identified
through colourful t-shirts with “Pee-in-a-Pot Volunteer”
printed on the back.
Screening approach
The approach used in the study was adapted during the
one week to maximise privacy for participants. While
testing packs were initially distributed in communal
areas: as the event progressed male and female toilet
areas became the focal point for testing. Packs were
distributed and made available around sinks, mirrors
and inside toilet cubicles, which led to more participants
self-selecting for screening. The most popular approach
was for students to pick up a pack themselves in the toi-
let cubicle. Male volunteers were allocated to male toi-
lets and male orientated entertainment venues, such as
snooker rooms while female volunteers were allocated
to female toilets and other communal areas.
Notification of results
Participants with negative results for chlamydia were
informed by way of a carefully worded standard SMS
text message (your recent test result was negative). Parti-
cipants with a positive result were telephoned by a med-
ical doctor and invited to attend for an appointment at
their respective student health units. Positive cases were
treated with 1 g of Azithromycin free of charge and
given a study information leaflet about their result. Posi-
tive cases were asked by a medical doctor for their con-
sent to be referred to the project nurse/health research
advisor for partner notification and follow-up. This pro-
ject nurse/health research advisor discussed partner
notification, further STI testing and sexual health educa-
tion by phone anonymously. Participants were then con-
tacted 3-6 months after treatment for a retest.
Data analysis
Chlamydia results, date of birth, mobile phone number,
outcomes for partner notification, STI testing and retest
results were entered on to a secure Microsoft ACCESS
database. Analysis was conducted through Statistical
Package for the Social Sciences (SPSS version 17). Cross
tabulation and descriptive frequencies between key vari-
ables were carried out.
Semi-structured interviews with participants
Following the one week screening event, participants in
both campuses were invited for an interview to explore
their views and experience of the event. A mass recruit-
ment email with an information sheet was sent via the
student unions intranet system inviting students who
had participated in the “pee-in-a-pot” for an interview.
All registered students in both campuses would have
received this mass email (HEI 1-16,470 and HEI 2 -
4,873) Potential participants were instructed to text
‘YES’ to a mobile phone number if they wanted to be
interviewed. Project researchers conducted interviews by
telephone after receipt of verbal consent. Participants
who tested positive for chlamydia were also invited for
an interview during their follow-up consultations. Inter-
views were anonymous and a gift voucher (€30) was
given to all interviewees.
A small number (7) of qualitative semi-structured
interviews were conducted (6 female, 1 male) by two
project researchers using a topic guide. Data saturation
was reached quickly. Transcripts were coded to identify
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ers. Thematic analysis was used to generate emerging
themes.
Results
Screening
Three and a half screening days were conducted in one
HEI (HEI 1) and three screening days were held in the
second (HEI 2). The latter campus is a more widely dis-
tributed campus with several buildings located in differ-
ent areas. A total of 538 tests were eligible for inclusion
in the study. A total of 1249 testing packs was distribu-
ted across the two campuses, of which 592 (47.5%) were
returned with specimens. Forty five tests (all of which
were negative) were received from participants outside
the target age range for the study (18-29 years) and
were excluded from the final analysis. Nine further tests,
which were excluded because of specimen labelling
errors or inadequate personal identifying information
were not analyzed.
Results of screening
Three hundred and thirty six (63%) of the study samples
were from women and 191 (35.5%) were male. The sex
of the participants was not given in eleven samples. The
mean age of participants was 21 years. The uptake rate
in HEI 1 was 37.2% (183/493) and in HEI 2 was 54.2%
(409/756).
T h eo v e r a l lc h l a m y d i ap o s i t i v i t yr a t ea m o n g s tp a r t i c i -
pants with test results was 3.9% (21/538) with 5% posi-
tive (17/336) in females and 2% (4/191) in males. The
highest rate in both age groups was amongst the 20-24
years (Table 1). Although differences are found in posi-
tivity rates and uptake between the HEIs, these are gen-
erally not statistically significant (see Table 1 and 2).
Case Management
Out of the twenty one positive cases, eighteen partici-
pants were treated for chlamydia. Three participants
w i t hap o s i t i v er e s u l tw e r en ot contactable. Reasons for
this included two incorrect mobile phone numbers and
one mobile phone was disconnected. The mean waiting
time for receiving test result was 4.5 weeks. Fifteen posi-
tive cases were treated at the student health units, two
were treated at their respective family doctors and one
positive case was treated at a genitourinary (GUM)
clinic in another country.
Partner notification was conducted with fifteen partici-
pants - ten by the project nurse/research health advisor
and five by a practice nurse from one of the HEIs. Con-
sent for referral to the project nurse/research health
advisor was not given by one participant and two
refused to discuss partner notification. Patient referrals
were the preferred options with thirteen of the positive
cases notifying their previous and current partners
themselves. Four provider referrals were conducted by
the project nurse/research health advisor.
All participants who tested positive were advised to
attend for further STI screening and appointments were
made for seven participants to attend the local GUM
clinic. In total, three participants went on to have further
STI screening and eleven participants did not attend for
further screening. No additional STIs were detected.
Interviews with participants
Themes that emerged during the interviews are identi-
fied under the sub-headings below. Respondents’ reac-
tions to the on-campus screening programme were
positive overall, ‘feeling it was a good experience’. Three
interviewees commented that they would take part in
such an event again
.. I thought it was a good idea because all the students
were on campus and I thought it was very easy to use.
(Interview 6. female)
Barriers to testing in clinical setting
Participants discussed factors which would deter young
people from testing in clinical settings. These factors
included embarrassment, difficulties talking about sexual
health and lack of knowledge about STIs. Attending a
clinical setting was perceived to be ‘more public’
through having to sit in waiting rooms.
Testing in non-clinical setting: Accessibility and convenience
of testing
All of the participants spoke very enthusiastically about
the convenience of having testing packs readily available
on-campus, especially in toilet facilities. ‘Hassle-free’,n o
fuss’, ‘handy’ and ‘easy to do’ were frequent comments
made by different interviewees. The ‘non-technical’ nat-
ure of urine testing was appreciated by many and the
fact participants could ‘do the test themselves’.
Well because it was convenient, it was just on campus,
it was something you didn’th a v et ol i k eg oas p e c i f i c
place and the way it was handled like. (Interview 2.
female)
Table 1 Positivity rate by sex and age group
Female Male
CT Pos (%) 95% CI CT Pos (%) 95% CI P
value*
Age
(years)
18-19 4/93 (4.3%) 0.18,8.42 1/56 (1.7%) 0,5.26 0.687
20-24 13/214 (6%) 2.87,9.27 3/112
(2.6%)
0,5.67 0.197
25-29 0/29 0/23
Total 17/336
(5%)
2.72,7.4 4/191 (2%) 0.06,4.12 0.1086
* P values calculated using Fishers exact test
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Respondents stressed the importance of the testing
being anonymous with interviewees feeling it was clearly
linked to the successful uptake. Testing was perceived
to be ‘ap r i v a t ei s s u e ’ for participants. Most felt that
they would not have participated if they had to give
their full names. The level of personal information
required (i.e. mobile phone number and date of birth)
for the event was deemed acceptable by all of the
interviewees.
No names, that was a bit I liked most, my number just
seems fine but I would hate to put down my name.
(Interview 2. female)
Less embarrassment
The ‘usual’ embarrassment and shame associated with
STI testing was perceived to be considerably reduced by
the event. Several participants stated they experienced
little-to-no embarrassment and shame because ‘everyone
was doing it’ (the test). However, one participant com-
mented that having peer volunteers distributing testing
packs in the bathroom may have caused embarrassment
to some students.
I didn’t think much of it; I know that some people were
a little bit embarrassed because there would have been a
queue into the bathroom while they were offering it.
(Interview 3. female)
However, as the event progressed and where logisti-
cally possible, testing packsw e r ep r o v i d e di nt o i l e t
cubicles,
I think a lot of people would have just been like, oh
well it’s in the cubicle with me, the box is right there,
there’s nothing stopping me, I’db es t u p i dn o tt od oi t
like, you know. (Interview 1. female)
Peace of mind
A common theme which emerged among respondents
was the positive impact of taking the test. Testing was
seen to give ‘peace of mind’ and ‘a sense of relief’.H a l f
of interviewees stated they felt pleased with themselves
because they felt they had taken a positive step towards
looking after their health.
....and you kind of have piece of mind because you feel
better about yourself because you feel that you’re looking
after yourself even though you didn’t actually get to the
doctor (Interview 1. female)
Non-medical nature of setting
The informal and casual approach to testing was raised
by many and contributed to the high participation rates.
Respondents enjoyed the ‘light hearted’ approach to
testing. Many commented on the use of the user
‘friendly’ language (such as pee-in-a-pot) and the ‘open-
ness’ of displaying testing materials along with the pre-
sence of peer volunteers/project staff wearing the
colourful t-shirts. All of these generated an atmosphere
of fun, taking the ‘fear factor’ out of testing for many.
Yeah and the whole approach to it wasn’t like eerie
you know, scary like. The way the name, “Pee in a Pot”
like, it’s catchy; it’s a bit more light-hearted than if you
were to actually to go to a proper clinic you know. (Inter-
view 4. male)
Contextualising the event and holding it during the
sexual health awareness week was important for two of
the interviewees as they believed students were ‘in that
frame of mind’.
....it was during SHAG week so there was a big empha-
sis on like safe sex and contraception and it just made
people really, really aware of what can happen. (Inter-
view 7. female)
Half of the respondents commented on the positive
role played by the student union and student health ser-
vices in the event as these actors were viewed as ‘trusted
sources’.
Use of peer volunteers
Interviewees felt that it was ‘a good idea’ to use peers in
the event. Age was important with most participants
Table 2 Test results of participants and positivity rates per setting
HEI 1. HEI 2.
Total CT Pos(%) 95% CI Total CT Pos(%) 95% CI P value*
Age (years)
18-19 41 2 (4.9%) 0,11.47 109 3 (2.8%) 0,5.82 0.61
20-24 105 8 (7.6%) 2.55,12.69 230 8 (3.5%) 1.11,5.85 0.106
25-29 21 0 32 0
Sex
Male 76 3 (3.9%) 0,8.33 115 1 (0.9%) 0,2.57 0.30
Female 82 7 (8.5%) 2.49,14.59 254 10 (3.9%) 1.55,6.33 0.14
Unknown 9 2
Total 167 10 (5.9%) 2.39,9.59 371 11 (2.9%) 1.24,4.68 0.146
*P values calculated using Fisher exact test
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themselves’. Perceptions that older persons have more
traditional views of sexual health were expressed while
the use of young people brought a more open and
‘modern’ outlook to the event.
Because they’re more, the older nurses would be like
more old fashioned and traditional I think, they’db e
like; oh you shouldn’t be doing something like that out-
side of marriage.......and like the younger nurse would be
more modern and understanding, you’db em o r ec o m f o r -
table with a younger person.... (Interview 7. female)
Test Results
Participants commented on the convenience of text
messages for negative results and were pleased with the
standard text that received which they felt protected
their privacy (chlamydia was not mentioned in the text).
It didn’t say what it was. Like the way the text message
was really good because only I would know what, it
didn’t say, it just said from a recent test or something
like that but it didn’t actually explicitly say you know, it
was done in a good way. (Interview 2. female)
Several participants commented on the delay for
results with two participants commented that they were
worried when they did not hear.
Recommendations for future testing
When asked about improvements for future testing,
most suggested that all testing kits and drop off boxes
could be located inside the toilet cubicle to allow for
complete privacy. Several interviewees felt the urine col-
lection drop off boxes should be secure for any future
event.
Is u p p o s ep u t t i n gt h es t u f fi n s i d et h ec u b i c l em a y b e
because then no one sees if you’re taking it or not. I
think more so for girls than boys. (Interview 3. female)
Discussion
This study showed on-campus screening for chlamydia
generated high uptake and was acceptable to students.
The discreetness of testing, where students could take
an anonymous chlamydia test in a toilet cubicle, sug-
gests a particular strength of the screening programme
design which ensured confidential testing. The overall
rate of infection of 3.9% in students was comparable to
that in other European studies [45-47]. The positivity
rate of 5% was found in females and is similar to that
reported by O’Connell et al. which found a rate of 4.8%
within a similar population attending student heath
units in the Republic of Ireland [48,49].
The rate (2%) found in males is broadly comparable to
European studies [30] and is slightly lower than UK
rates [50]. Positivity rates were generally higher in HEI 1
than in HEI 2, among females 8.5% (7/82) compared to
3.9% (10/254) and among males 3.9% (3/76) compared
to 0.9% (1/115). However, differences were based on
small numbers, precluding inferences to the larger
populations.
Gender difference in uptake
Overall male participation in the event was lower (191)
than female (336). The lower number of males taking
up testing in the testing, although no statistically signifi-
cant suggest that males may distance themselves from
chlamydia by labelling it as a ‘women’s disease’ as has
been reported [51]. Others have commented that males
are less likely to accept screening than females [52,53].
Possible reasons may be that males are less knowledge-
able about chlamydia than females of the same age
[54,55]; and males may become more embarrassed,
anxious and ashamed about being asked to take part in
chlamydia screening programmes [56]. Given the nature
of male toilet facilities where there are fewer private
cubicles, men may have felt more inhibited about taking
the test privately in a toilet cubicle or might not have
wanted to take the time.
There were also differences between the settings in
the proportions of males and females who accepted the
screening offer, being almost equal in HEI 1 (75:73),
while in HEI 2 there were nearly twice as many women
as men (244:114). Reasons may include: there were
more male peer volunteers circulating in the HEI 1
campus who were very pro-active and enthusiastic
about the event, interacting more with potential male
participants. Male volunteers in the HEI 1 were also in
the toilets areas distributing tests kits more frequently.
Some of the male volunteers were representatives of the
student union and may have been known to many of
the potential participants. As one interviewee commen-
ted during the interview, the HEI 1 Student Union is
regarded as a “trusted source” by students.
The proportion (35.5%) of males in the event compares
favourably to a UK chlamydia screening postal study [57]
which showed a lower participation rate (18.9%) of those
males offered screening. While male participation is
encouraging given the evidence young males are often
identified as a difficult population to reach [58-60] and
have different health seeking behaviour than females
[61], an Australian study found cash incentives encour-
aged male participation in screening [62].
Screening model
The screening approach used and developed in this study
demonstrates several advantages. Narratives in the inter-
views show the importance of normalising testing. The
‘openness’ and ‘lighted hearted, fun’ approach removed the
fear factor often associated with STI testing and helped to
normalise testing. Participants welcomed the ‘informal and
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ure of urine testing was ‘easy to do’ and participants
appreciated ‘doing the test themselves’. The psychosocial
impact of testing was commented on in the narratives
with testing giving more than half of the participants
‘peace of mind’ and feeling good about ‘taking responsibil-
ity for their health’. This is consistent with other studies
[63] which suggest testing for chlamydia has the effect of
relieving rather than creating anxiety [64].
Participant’s emphasised the importance of accessibil-
ity and convenience during the interviews, which is con-
sistent with others’ findings: young people are less likely
to accept screening if they believe that screening will
inconvenience them [65-67]. Privacy and anonymity was
also crucial to uptake. This model provides a successful
framework which offers convenient and accessible test-
ing which ensures privacy and confidentiality for partici-
pants. The model developed and tested in these two
HEIs now needs to be refined before replication. As
raised in the interviews, some participants may have
been embarrassed by testing kits been handed out in
toilet areas. To further enhance privacy and minimise
social embarrassment, the model could be tailored to
locate all testing packs and collection boxes within toilet
cubicles as recommended by several interviewees.
This approach may prove to be a useful model to use
i naw i d e rv a r i e t yo fn o n - c l i nical community settings.
Community based settings for early school leavers, pro-
bation and homeless services could be explored as well
as non-educational settings such as employment occupa-
tional health settings. This model does not seek to
replace the need for clinical based screening but rather
utilises opportunities to reach target populations who
use clinical settings infrequently or who might be reluc-
tant to accept STI screening offers in such settings. This
model may also prove to be considerably less expensive
than screening in clinical settings, and a paper present-
ing a cost effectiveness analysis of this approach is in
preparation. While the UK National Chlamydia Screen-
ing Programme (NSCP) has a portfolio of approaches to
screening, it also encourages screening opportunities in
commercial pharmacies, universities, colleges, and other
venues. Engaging other venues can maximise access and
opportunities to reach target populations especially the
more difficult to reach young people [68].
The study had some limitations. While the use of peer
volunteers appeared to generate an ‘informal and light
hearted’ approach, the full impact of their involvement
was not explored.
Numbers tested were small, based on only two HEIs
and might not be representative of the total population
of students in HEIs.
Despite all registered students in both campuses
receiving the mass recruitment email inviting
participants for an anonymous interview, the respond
rate was low with only 7 interviews being conducted. It
is uncertain as to the low number of respondents.
Conclusions
This study demonstrated that on-campus self-selected
screening and confidential testing is feasible and
acceptable to students (during SHAG week when par-
ticipants were open to and used to seeing information
and guidance on sexual health). The benefit of using
this strategy is that it can detect asymptomatic cases
of chlamydia in these young people. It eliminates
many of the barriers associated with STI testing in
clinical settings because it is easy to access, conveni-
ent, confidential and private. It helps to promote chla-
mydia testing as “responsible behaviour” and it
normalises testing [69].
The study contributes to the growing body of evidence
around the effectiveness of screening approaches in
non-clinical settings and helps to identify gaps identified
in the literature [70]. Third level education institutions
(HEIs) provide an easily accessible population, where
screening is acceptable if discretely available.
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